Additional investigation into the activity of the DS LCAT activators, more specifically DS-8190a (2,Figure 4), demonstrated its ability to prevent the progression of plaque accumulation in atherosclerosis models, and the selectivity of its binding to LCAT (Sasaki et al., 2021). This evidence concerns the gene LCAT and atherosclerosis.